Medicine and Dentistry
X Linked Hypophosphatemic Rickets
100%
Pediatrics
67%
Burosumab
51%
Disease
45%
Adolescent
43%
Fibroblast Growth Factor 23
42%
Osteoporosis
33%
Diabetes
33%
Pediatric Endocrinology
33%
Interim Analysis
33%
Vitamin D
25%
Rickets
24%
Isotopes of Calcium
22%
Health Care Provider
22%
Exon
20%
Consultation
19%
Phosphate Metabolism
18%
Short Stature
18%
Monoclonal Antibody
18%
Parathyroid Hormone
18%
Prospective Study
16%
Cardiovascular Risk
16%
Rare Disease
16%
Genetic Analysis
16%
Patient with Type 1 Diabetes
16%
Insulin Dependent Diabetes Mellitus
16%
Oligodontia
16%
Developmental Delay
16%
Brachydactyly
16%
Hypovitaminosis D
16%
Vitamin D Deficiency
16%
Adolescence
16%
Underweight
16%
Osseointegration
16%
Calcitriol
13%
Supplementation
10%
Drug Therapy
9%
Speech Development
8%
Language Development
8%
Speech and Language
8%
Observational Study
8%
Clinician
8%
Research Design
8%
Personal Experience
8%
Health Care Cost
8%
Health Care
8%
Spine Fracture
7%
Nephrocalcinosis
6%
Diagnosis
6%
Bone Mass
6%
Keyphrases
Fibroblast Growth Factor 23 (FGF23)
33%
X-linked Hypophosphataemia
33%
X-linked Hypophosphatemia
33%
Burosumab
33%
Body Size
16%
Treatment Experience
16%
Adolescent Experiences
16%
Novel mutation
16%
CYP2R1
16%
Calcium-phosphorus Metabolism
16%
Monoclonal Antibody
16%
Type I Diabetes
16%
Hematological Malignancies
16%
Cardiovascular Risk
16%
Sudanese
16%
Size Composition
16%
Molecular Genetic Analysis
16%
Seven Years Follow-up
16%
Patient-centered
16%
Prospective Cohort Study
16%
Osteoporosis in children
16%
Sustained Efficacy
16%
Multi-stakeholder
16%
Type 1 Diabetes Mellitus (T1DM)
16%
Body Composition
16%
Observational Prospective Study
16%
Learning Website
16%
Clinical Presentation
16%
Childhood Cancer Survivors
16%
Tertiary Hyperparathyroidism
16%
Pediatric Patients
16%
Working Diagnosis
13%
Brain Malignancies
13%
Extraskeletal Effects
12%
Rare Diseases
11%
Exon 1
11%
Rickets
9%
Brachydactyly Type E
8%
BMI Z-score
8%
Fat Mass
8%
Fat-free Mass
8%
Hypercalcemia
8%
Calcitriol
7%
Conventional Therapy
6%
Cinacalcet
6%
Patient Caregivers
5%
Point mutation
5%
Liver Disease
5%
Consanguineous
5%
Solid Tumors
5%
Pharmacology, Toxicology and Pharmaceutical Science
Vitamin D
35%
X-Linked Hypophosphatemia
33%
Spine Fracture
33%
Bone Fragility
25%
Secondary Osteoporosis
25%
Disease
20%
Prospective Cohort Study
18%
Short Stature
18%
Prospective Study
16%
Bisphosphonic Acid Derivative
16%
Brain Tumor
16%
Childhood Cancer
16%
Obesity
16%
Burosumab
16%
Inflammation
16%
Skeleton Malformation
16%
Malignant Neoplasm
16%
Rare Disease
16%
Solid Malignant Neoplasm
16%
Muscle Disease
16%
Scoliosis
16%
Hematologic Malignancy
16%
Leukemia
16%
Recurrent Disease
16%
Neurologic Disease
16%
Somatomedin C
16%
Growth Hormone
16%
Vitamin D Deficiency
11%
Hypovitaminosis D
11%
Observational Study
8%
Chronic Disease
8%
Population Study
8%
Acute Disease
8%
Bone Disease
8%
Underweight
8%
Prevalence
8%
Duchenne Muscular Dystrophy
8%
Rickets
7%
